Allergan plc announced that two pivotal trials of the Oculeve Intranasal Tear Neurostimulator, OCUN-009 and OCUN-010, each met their primary...
Read moreMerck, known as MSD outside the United States and Canada, announced that the U.S. FDA has granted Breakthrough Therapy Designation...
Read moreThis whitepaper highlights some of the most advanced companies in their innovative approaches to trial recruitment. Witness first-hand 5 case...
Read moreAbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the online publication of new data in the New England Journal...
Read moreAbbVie , a global biopharmaceutical company, announced preliminary data from the ongoing Phase 1/2b PCYC-1119 trial suggesting that the combination of...
Read more- IMBRUVICA ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN KEY ENDPOINTS INCLUDING REDUCTION OF THE RISK OF DISEASE PROGRESSION OR DEATH VERSUS...
Read moreClinical trial to assess safety and efficacy of immuno-oncology combination in patients with advanced NSCLC or melanoma Syndax Pharmaceuticals,...
Read moreMerck (NYSE:MRK), known as MSD outside the United States and Canada, and DNAtrix today announced they have entered into an...
Read more• 11 billion euro R&D programme through 2020, with 5 billion euro dedicated to pre-clinical R&D and 1.5 billion euro...
Read morePhase III clinical trial for BI695501, a biosimilar candidate for AbbVie’s Humira®, fully enrolledRecently announced Phase I trial results show...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
